SIRTORI, CESARE
 Distribuzione geografica
Continente #
EU - Europa 38.303
AS - Asia 21.485
NA - Nord America 20.782
SA - Sud America 1.997
AF - Africa 387
OC - Oceania 131
Continente sconosciuto - Info sul continente non disponibili 19
Totale 83.104
Nazione #
US - Stati Uniti d'America 20.179
IT - Italia 12.632
GB - Regno Unito 9.182
SG - Singapore 6.398
CN - Cina 6.377
DE - Germania 5.740
RU - Federazione Russa 2.399
SE - Svezia 2.378
VN - Vietnam 1.773
HK - Hong Kong 1.762
NL - Olanda 1.531
BR - Brasile 1.346
TR - Turchia 1.312
FR - Francia 1.168
IN - India 1.030
KR - Corea 884
UA - Ucraina 833
IE - Irlanda 768
FI - Finlandia 600
BD - Bangladesh 569
EU - Europa 525
CA - Canada 336
ID - Indonesia 315
JP - Giappone 265
CO - Colombia 232
GR - Grecia 203
PL - Polonia 164
MX - Messico 153
AR - Argentina 140
ES - Italia 136
PH - Filippine 127
AU - Australia 115
IQ - Iraq 89
CL - Cile 87
DK - Danimarca 86
BE - Belgio 79
CI - Costa d'Avorio 75
TH - Thailandia 70
AT - Austria 69
SA - Arabia Saudita 68
ZA - Sudafrica 64
EC - Ecuador 62
CH - Svizzera 59
EG - Egitto 50
PK - Pakistan 47
VE - Venezuela 45
IR - Iran 44
UZ - Uzbekistan 43
TW - Taiwan 38
RO - Romania 37
MY - Malesia 35
CZ - Repubblica Ceca 33
PE - Perù 33
IL - Israele 32
PT - Portogallo 32
MA - Marocco 30
JO - Giordania 28
NO - Norvegia 26
PY - Paraguay 26
TN - Tunisia 25
KE - Kenya 23
NP - Nepal 23
AZ - Azerbaigian 22
AE - Emirati Arabi Uniti 21
DZ - Algeria 20
HU - Ungheria 18
JM - Giamaica 18
PS - Palestinian Territory 17
RS - Serbia 15
AL - Albania 14
BG - Bulgaria 14
TT - Trinidad e Tobago 14
CR - Costa Rica 13
ET - Etiopia 13
KZ - Kazakistan 13
NZ - Nuova Zelanda 13
BO - Bolivia 12
HR - Croazia 12
LU - Lussemburgo 12
UY - Uruguay 12
GT - Guatemala 11
LT - Lituania 11
NG - Nigeria 11
SN - Senegal 10
BH - Bahrain 9
BY - Bielorussia 9
DO - Repubblica Dominicana 9
LB - Libano 9
LV - Lettonia 9
PA - Panama 9
RE - Reunion 9
LY - Libia 8
QA - Qatar 8
SC - Seychelles 8
SY - Repubblica araba siriana 8
MD - Moldavia 7
OM - Oman 7
GE - Georgia 6
HN - Honduras 6
LA - Repubblica Popolare Democratica del Laos 6
Totale 83.473
Città #
Southend 8.558
Singapore 3.754
Hanover 2.748
Milan 1.841
Hong Kong 1.676
Ashburn 1.604
Chandler 1.552
Seattle 1.465
San Jose 1.400
Beijing 1.263
Princeton 1.002
Wilmington 867
Rome 836
Council Bluffs 807
Dublin 748
Dallas 606
Fairfield 605
Redmond 605
Frankfurt am Main 507
Mountain View 492
Santa Clara 491
Los Angeles 472
Jacksonville 442
Nanjing 442
Ann Arbor 418
Lauterbourg 413
Sakarya 407
Bengaluru 392
Houston 379
Woodbridge 377
Ho Chi Minh City 339
Dong Ket 325
Moscow 319
Des Moines 317
Hanoi 302
Buffalo 292
Dearborn 285
Boardman 277
New York 276
Guangzhou 273
Turin 266
Grafing 231
Naples 225
Bologna 222
Shanghai 221
Jinan 208
Serra 208
Somerville 200
Andover 197
Cambridge 189
Shenyang 186
Jakarta 176
Bogotá 173
Berlin 171
Athens 164
Tianjin 162
Palermo 156
The Dalles 154
Tokyo 152
Florence 149
Eitensheim 147
Toronto 146
Redwood City 145
Helsinki 139
Changsha 135
Hefei 134
Nanchang 134
Hebei 132
Seoul 132
Phoenix 127
Cangzhou 122
Columbus 122
Munich 120
São Paulo 115
Bari 110
Shenzhen 105
Zhengzhou 98
Hangzhou 94
Bitonto 91
Catania 90
Verona 89
Saint Petersburg 85
Sunnyvale 78
Modena 74
Abidjan 72
San Diego 71
Genoa 70
Warsaw 68
Ningbo 66
Istanbul 64
Bangalore 62
Da Nang 62
Fuzhou 60
Medford 60
Brescia 57
Brussels 57
Washington 56
Padua 55
Chicago 54
Jiaxing 54
Totale 47.736
Nome #
L’ispessimento medio-intimale della carotide comune è veramente un indice di coronaropatia in pazienti asintomatici? 8.646
L’ispessimento medio-intimale delle carotidi extracraniche nel riconoscimento del paziente con e senza eventi vascolari 1.441
OMEGA-3 AND CARDIOVASCULAR PREVENTION - IS THIS STILL A CHOICE? 703
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure 487
Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells 453
Functional Lecithin : Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans 440
Long-term fasting improves lipoprotein-associated atherogenic risk in humans 437
Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation 418
Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956/1 413
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure 408
Cardiovascular status of carriers of the apolipoprotein A-I-Milano mutant - The Limone sul Garda study 396
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I 387
High-density lipoprotein deficiency in genetically modified mice deeply affects skin morphology : A structural and ultrastructural study 385
Calcolo del rischio cardiovascolare in prevenzione primaria e secondaria ed aterosclerosi carotidea 360
n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes 360
Influence of body variables in the development of metabolic syndrome : A long term follow-up study 354
Nutraceuticals for blood pressure control 351
Acute effect of Tetranectin-ApoA-I infusion on atherosclerosis progression/regression in hypercholesterolemic rabbits 349
Lipid-lowering drugs 344
Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors 340
Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model 337
Unravelling the health effects of fasting : a long road from obesity treatment to healthy life span increase and improved cognition 336
PPAR-α agonists are still on the rise: an update on clinical and experimental findings 328
Effect of the combinations between pea proteins and soluble fibres on cholesterolaemia and cholesterol metabolism in rats 326
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 308
Waist-to-height ratio is a highly sensitive index for the metabolic syndrome in a mediterranean population 305
PPAR Agonists and Metabolic Syndrome : An Established Role? 295
Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis 294
Chronic use of light or heavy cigarettes and carotid IMT 293
Lipid-lowering therapy of everolimus-related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET) 289
An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma Cholesterol-Lowering Activity in apoE(-/-) Mice 287
Maternal exposure to air pollutants, PCSK9 levels, fetal growth and gestational age – An Italian cohort 287
Valutazione dei benefici salutistici dell'assunzione dI proteine della soia in pazienti con moderata sindrome metabolica 285
Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant 281
A new noninvasive method for the accurate and precise assessment of varicose vein diameters 281
Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients 273
Beneficial effects of lupin proteins : a novel source of hypocholesterolemic agents? 270
Large waist circumference with normal BMI identifies a significant subset of Italian female patients with the metabolic syndrome : a high risk presentation? 269
Eicosapentaenoic acid for prevention of major coronary events 264
Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke 262
Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion 258
PUÒ UN CONSUMO MODERATO DI SIGARETTE ESSERE CONSIDERATO UNA VALIDA ALTERNATIVA ALLA CESSAZIONE DEL FUMO? 257
Effect of n-3 fatty acids on carotid atherosclerosis and hemostasis in hypertriglyceridemic patients: a double blind pilot study in primary prevention 257
Evaluation of the health benefits of soy protein consumption in patients carrying the metabolic syndrome 255
A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis 254
Recognition of patients with cardiovascular disease by artificial neural networks 253
Effetto dell'abitudine al fumo sulla relazione tra fattori di rischio aterosclerotico ed IMT carotideo 252
Normal endothelial function in carriers of the apolipoprotein A-IMilano mutant despite low HDL-cholesterol levels 248
Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients 248
A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in apoE-deficient mice 248
Nutraceutical approach to moderate cardiometabolic risk : results of a randomized, double-blind and crossover study with Armolipid Plus 247
Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits 246
Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate 242
Paradoxical decrease in high density lipoprotein cholesterol with fenofibrate : a quite rare phenomenon indeed 242
Development of a model based on body composition to predict drug kinetics: II. Application of the model to the use of digoxin in elderlies 236
Correlation of parents' longevity with carotid intima-media thickness in patients attending a Lipid Clinic 235
Statin therapy and related risk of new-onset type 2 diabetes mellitus 235
CORRELAZIONE TRA SPESSORE MEDIO-INTIMALE, PLACCHE CAROTIDEE E LESIONI CORONARICHE 234
CHRONIC USE OF LIGHT OR HEAVY CIGARETTES AND CAROTID IMT 233
Le basi farmacologiche della terapia 231
Effects of cigarette smoking on the relationship between fatty acids and subclinical atherosclerosis 231
Cholesterol-lowering effect of dietary Lupinus angustifolius proteins in adult rats through regulation of genes involved in cholesterol homeostasis 231
A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies 230
PARENTS’ LONGEVITY AS PREDICTOR OF CAROTID ATHEROSCLEROSIS 230
Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention 229
Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia 228
Colesterolo HDL e aterosclerosi carotidea 228
Effect of omega-3 PUFA on carotid IMT and haemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 227
Relationship between cardiovascular global risk in primary and secondary prevention and carotid atherosclerosis 227
Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia 227
Circulating Lipid and Lipoprotein Levels Distinguish a Gender-Related Response to Statins in Subjects in Primary and Secondary Prevention 224
Hypocholesterolaemic effects of lupin protein and pea protein/fibre combinations in moderately hypercholesterolaemic individuals 223
Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini 221
CHRONIC USE OF LIGHT OR REGULAR CIGARETTES AND FLOW MEDIATED DILATION 221
LCAT e spessore medio intimale carotideo in individui europei ad alto rischio cardiovascolare 221
Analysis of Lupinus albus storage proteins by two-dimensional electrophoresis and mass spectrometry 220
ARTIFICIAL NEURAL NETWORKS IN THE RECOGNITION OF PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE 219
Time course of forearm arterial compliance changes during reactive hyperemia 219
Algorithm developed by the Italian “Istituto Superiore di Sanità” (Cuore Risk Score) : assessment of its capacity to predict global cardiovascular risk in dyslipidemic patients 217
LONGEVITA’ DEI GENITORI ED ATEROSCLEROSI CAROTIDEA 216
Combined use of carotid IMT and traditional risk factors in predicting cardiovascular events in intermediate risk individuals 216
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance 216
CAROTID INTIMA-MEDIA THICKNESS (C-IMT) : BIOMARKER, SURROGATE END POINT OR BOTH? 215
Different activity profile of ß-cyclodextrin and hydroxypropyl-ß-cyclodextrin in hyperlipidemic animal models 214
Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients 213
Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL 212
Measurement of carotid artery intima-media thickness improves the power of traditional risk factors to predict cardiovascular events 211
Food-derived peptides with hypocholesterolemic activity: Production, transepithelial transport and cellular mechanisms 210
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a) 210
Le basi farmacologiche della terapia 210
Le basi farmacologiche della terapia : il manuale 207
Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements 207
Viability of developing CETP inhibitors 206
SMOKING HABITS AS DETERMINANT OF CAROTID IMT IN PATIENTS IN PRIMARY AND SECONDARY PREVENTION 204
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia 204
Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins 203
ALTERATIONS IN HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS DURING POSTPRANDIAL LIPIDEMIA INDUCED BY FAT WITH AND WITHOUT ETHANOL 202
Farmacoterapia cardiovascolare 201
Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors 200
Effect of plasma cholesterol reduction by pravastatin on the functional properties of forearm arteries in hypercholesterolemic patients 200
Totale 36.903
Categoria #
all - tutte 204.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.433 0 0 0 0 0 0 0 0 0 0 1.629 804
2021/20227.978 598 289 392 638 742 808 661 611 768 863 688 920
2022/20236.285 842 464 525 686 720 1.246 190 373 603 124 356 156
2023/20244.630 175 380 263 364 952 336 229 321 119 373 487 631
2024/202510.211 430 824 197 940 801 493 405 1.249 627 997 1.054 2.194
2025/202625.607 1.972 1.195 2.630 2.195 2.741 2.115 3.161 2.275 3.071 2.320 1.932 0
Totale 87.241